Business Summary
Number of employees: 376
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Endicott
CEO | Chief Executive Officer | 58 | 22-11-20 |
Andrew Allen
CMP | Compliance Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 22-02-28 | |
Chief Tech/Sci/R&D Officer | - | 20-02-02 | |
David Biddell
PRN | Corporate Officer/Principal | - | - |
Leon J. Atencia
PRN | Corporate Officer/Principal | - | 21-07-14 |
Evan Hockman
SAM | Sales & Marketing | - | - |
Wanda Francies
HRO | Human Resources Officer | - | - |
Kenji Aso
PRN | Corporate Officer/Principal | - | - |
Gerry McKenzie
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Bell
BRD | Director/Board Member | 54 | 22-11-20 |
Chairman | 57 | 22-11-20 | |
Jonathan Balch
BRD | Director/Board Member | - | 22-11-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 49,417,407 | 49,245,119 ( 99.65 %) | 0 | 99.65 % |
Company contact information
Aerie Pharmaceuticals, Inc.
6201 South Freeway
76134, Forth Worth
+919 237 5300
http://www.aeriepharma.comSector
1st Jan change | Capi. | |
---|---|---|
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |